# Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature

> **NCT01786902** · PHASE3 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 70 (actual)

## Conditions studied

- Idiopathic Short Stature

## Interventions

- **DRUG:** DA-3002

## Key facts

- **NCT ID:** NCT01786902
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2017-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01786902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01786902, "Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01786902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*